Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

01-12-2021 | Tuberculosis | Research

Trends in incidence and mortality of tuberculosis in India over past three decades: a joinpoint and age–period–cohort analysis

Authors: Deepak Dhamnetiya, Priyanka Patel, Ravi Prakash Jha, Neha Shri, Mayank Singh, Krittika Bhattacharyya

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Tuberculosis, as a communicable disease, is an ongoing global epidemic that accounts for high burden of global mortality and morbidity. Globally, with an estimated 10 million new cases and around 1.4 million deaths, TB has emerged as one of the top 10 causes of morbidity and mortality in 2019. Worst hit 8 countries account for two thirds of the new TB cases in 2019, with India leading the count. Despite India's engagement in various TB control activities since its first recognition through the resolution passed in the All-India Sanitary Conference in 1912 and launch of first National Tuberculosis Control Programme in 1962, it has remained a major public health challenge to overcome. To accelerate progress towards the goal of ending TB by 2025, 5 years ahead of the global SDG target, it is imperative to outline the incidence and mortality trends of tuberculosis in India. This study aims to provide deep insights into the recent trends of TB incidence and mortality in India from 1990 to 2019.

Methods

This is an observational study based on the most recent data from the Global Burden of Disease (GBD) Study 2019. We extracted numbers, age-specific and age-standardized incidence and mortality rates of Tuberculosis for the period 1990–2019 from the Global Health Data Exchange. The average annual percent change (AAPC) along with 95% Confidence Interval (CI) in incidence and mortality were derived by joinpoint regression analysis; the net age, period, and cohort effects on the incidence and mortality rates were estimated by using Age–Period–Cohort model.

Results

During the study period, age-standardized incidence and mortality rates of TB in India declines from 390.22 to 223.01 and from 121.72 to 36.11 per 100,000 population respectively. The Joinpoint regression analysis showed a significant decreasing pattern in incidence rates in India between 1990 and 2019 for both male and female; but larger decline was observed in case of females (AAPC: − 2.21; 95% CI: − 2.29 to − 2.12; p < 0.001) as compared to males (AAPC: − 1.63; 95% CI: − 1.71 to − 1.54; p < 0.001). Similar pattern was observed for mortality where the declining trend was sharper for females (AAPC: − 4.35; 95% CI: − 5.12 to − 3.57; p < 0.001) as compared to males (AAPC: − 3.88; 95% CI: − 4.63 to − 3.11; p < 0.001). For age-specific rates, incidence and mortality rates of TB decreased for both male and female across all ages during this period. The age effect showed that both incidence and mortality significantly increased with advancing age; period effect showed that both incidence and mortality decreased with advancing time period; cohort effect on TB incidence and mortality also decreased from earlier birth cohorts to more recent birth cohorts.

Conclusion

Mortality and Incidence of TB decreased across all age groups for both male and female over the period 1990–2019. The incidence as well as mortality was higher among males as compared to females. The net age effect showed an unfavourable trend while the net period effect and cohort effect presented a favourable trend. Aging was likely to drive a continued increase in the mortality of TB. Though the incidence and mortality of tuberculosis significantly decreased from 1990 to 2019, the annual rate of reduction is not sufficient enough to achieve the aim of India’s National Strategic plan 2017–2025. Approximately six decades since the launch of the National Tuberculosis Control Programme, TB still remains a major public health problem in India. Government needs to strengthen four strategic pillars “Detect–Treat–Prevent–Build” (DTPB) in order to achieve TB free India as envisaged in the National Tuberculosis Elimination Programme (2020).
Appendix
Available only for authorised users
Literature
1.
go back to reference Pai M, Correa N, Mistry N, Jha P. Reducing global tuberculosis deaths—time for India to step up. Lancet. 2017;389(10075):1174–6.PubMed Pai M, Correa N, Mistry N, Jha P. Reducing global tuberculosis deaths—time for India to step up. Lancet. 2017;389(10075):1174–6.PubMed
2.
go back to reference World Health Organization. Global tuberculosis report 2013. World Health Organization; 2013. World Health Organization. Global tuberculosis report 2013. World Health Organization; 2013.
4.
go back to reference World Health Organization. Global tuberculosis report 2018. Geneva: WHO; 2017. World Health Organization. Global tuberculosis report 2018. Geneva: WHO; 2017.
5.
go back to reference Arinaminpathy N, Batra D, Khaparde S, Vualnam T, Maheshwari N, Sharma L, Dewan P. The number of privately treated tuberculosis cases in India: an estimation from drug sales data. Lancet Infect Dis. 2016;16(11):1255–60.PubMedPubMedCentral Arinaminpathy N, Batra D, Khaparde S, Vualnam T, Maheshwari N, Sharma L, Dewan P. The number of privately treated tuberculosis cases in India: an estimation from drug sales data. Lancet Infect Dis. 2016;16(11):1255–60.PubMedPubMedCentral
6.
go back to reference Mazumdar S, Satyanarayana S, Pai M. Self-reported tuberculosis in India: evidence from NFHS-4. BMJ Glob Health. 2019;4(3):e001371.PubMedPubMedCentral Mazumdar S, Satyanarayana S, Pai M. Self-reported tuberculosis in India: evidence from NFHS-4. BMJ Glob Health. 2019;4(3):e001371.PubMedPubMedCentral
7.
go back to reference Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Gilpin C, et al. WHO’s new end TB strategy. Lancet. 2015;385(9979):1799–801.PubMed Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Gilpin C, et al. WHO’s new end TB strategy. Lancet. 2015;385(9979):1799–801.PubMed
8.
go back to reference Central TB Division, Directorate General of Health services, Ministry of Health and Family Welfare, Nirman Bhavan ND. National strategic plan for tuberculosis elimination 2017–2025. 2017. Central TB Division, Directorate General of Health services, Ministry of Health and Family Welfare, Nirman Bhavan ND. National strategic plan for tuberculosis elimination 2017–2025. 2017.
9.
go back to reference Indian Council of Medical Research. Tuberculosis Sub-Committee. Tuberculosis in India: a sample survey, 1955–58. 1959. Indian Council of Medical Research. Tuberculosis Sub-Committee. Tuberculosis in India: a sample survey, 1955–58. 1959.
10.
go back to reference Onozaki I, Law I, Sismanidis C, Zignol M, Glaziou P, Floyd K. National tuberculosis prevalence surveys in Asia, 1990–2012: an overview of results and lessons learned. Trop Med Int Health. 2015;20(9):1128–45.PubMed Onozaki I, Law I, Sismanidis C, Zignol M, Glaziou P, Floyd K. National tuberculosis prevalence surveys in Asia, 1990–2012: an overview of results and lessons learned. Trop Med Int Health. 2015;20(9):1128–45.PubMed
11.
go back to reference Narain JP, Lo YR. Epidemiology of HIV-TB in Asia. Indian J Med Res. 2004;120:277–89.PubMed Narain JP, Lo YR. Epidemiology of HIV-TB in Asia. Indian J Med Res. 2004;120:277–89.PubMed
12.
go back to reference Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber Lung Dis. 1992;73(6):311–21.PubMed Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber Lung Dis. 1992;73(6):311–21.PubMed
13.
go back to reference Swaminathan S, Narendran G. HIV and tuberculosis in India. J Biosci. 2008;33(4):527–37.PubMed Swaminathan S, Narendran G. HIV and tuberculosis in India. J Biosci. 2008;33(4):527–37.PubMed
14.
go back to reference Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, Silva G, Santos J, Wells C, Paine P, Garrett D. Impact of antiretroviral therapy on the incidence of tuber-culosis: the Brazilian experience, 1995–2001. PLoS ONE. 2007;2:e826.PubMedPubMedCentral Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, Silva G, Santos J, Wells C, Paine P, Garrett D. Impact of antiretroviral therapy on the incidence of tuber-culosis: the Brazilian experience, 1995–2001. PLoS ONE. 2007;2:e826.PubMedPubMedCentral
15.
go back to reference Williams BG, Granich R, Chauhan LS, Dharmshaktu NS, Dye C. The impact of HIV/AIDS on the control of tuberculosis in India. Proc Natl Acad Sci. 2005;102(27):9619–24.PubMedPubMedCentral Williams BG, Granich R, Chauhan LS, Dharmshaktu NS, Dye C. The impact of HIV/AIDS on the control of tuberculosis in India. Proc Natl Acad Sci. 2005;102(27):9619–24.PubMedPubMedCentral
16.
go back to reference India TB report. Revised National TB control programme, Central TB Division, MOHFW, India. 2019. India TB report. Revised National TB control programme, Central TB Division, MOHFW, India. 2019.
17.
go back to reference Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M, Bhutta ZA. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22. Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M, Bhutta ZA. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.
18.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, AlMazroa MA, Remuzzi G. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.PubMed Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, AlMazroa MA, Remuzzi G. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.PubMed
19.
go back to reference Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Health Metr. 2012;10(1):1–23.PubMedPubMedCentral Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Health Metr. 2012;10(1):1–23.PubMedPubMedCentral
20.
go back to reference Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, Wikler D, Lopez AD. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063–6.PubMed Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, Wikler D, Lopez AD. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063–6.PubMed
21.
go back to reference Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, Dansereau EA, Graetz N, Barber RM, Brown JC, Wang H, Jacobsen KH. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005–70.PubMedPubMedCentral Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, Dansereau EA, Graetz N, Barber RM, Brown JC, Wang H, Jacobsen KH. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005–70.PubMedPubMedCentral
23.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.PubMed Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.PubMed
24.
go back to reference Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat. Med. 2009;28:3670–82.PubMedPubMedCentral Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat. Med. 2009;28:3670–82.PubMedPubMedCentral
25.
go back to reference Dye C, Lönnroth K, Jaramillo E, Williams BG, Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ. 2009;87:683–91.PubMedPubMedCentral Dye C, Lönnroth K, Jaramillo E, Williams BG, Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ. 2009;87:683–91.PubMedPubMedCentral
26.
go back to reference Yang Y, Fu WJ, Land KC. A methodological comparison of age–period–cohort models: the intrinsic estimator and conventional generalized linear models. Sociol Methodol. 2004;34(1):75–110. Yang Y, Fu WJ, Land KC. A methodological comparison of age–period–cohort models: the intrinsic estimator and conventional generalized linear models. Sociol Methodol. 2004;34(1):75–110.
27.
go back to reference Yang Y, Land KC. Age–period–cohort analysis: New models, methods, and empirical applications. Taylor & Francis; 2013. Yang Y, Land KC. Age–period–cohort analysis: New models, methods, and empirical applications. Taylor & Francis; 2013.
28.
go back to reference Robertson C, Gandini S, Boyle P. Age–period–cohort models: a comparative study of available methodologies. J Clin Epidemiol. 1999;52:569–83.PubMed Robertson C, Gandini S, Boyle P. Age–period–cohort models: a comparative study of available methodologies. J Clin Epidemiol. 1999;52:569–83.PubMed
29.
go back to reference Wang Z, Hu S, Sang S, Luo L, Yu C. Age–period–cohort analysis of stroke mortality in China: data from the Global Burden of Disease Study 2013. Stroke. 2017;48(2):271–5.PubMed Wang Z, Hu S, Sang S, Luo L, Yu C. Age–period–cohort analysis of stroke mortality in China: data from the Global Burden of Disease Study 2013. Stroke. 2017;48(2):271–5.PubMed
30.
go back to reference Xiaxue 2020: Age–period–cohort analysis of kidney cancer deaths attributable to high body-mass index in China and U.S. adults. 2020. Xiaxue 2020: Age–period–cohort analysis of kidney cancer deaths attributable to high body-mass index in China and U.S. adults. 2020.
31.
go back to reference Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics. 1983;39:311–24.PubMed Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics. 1983;39:311–24.PubMed
32.
go back to reference Yang HP, Anderson WF, Rosenberg PS, Trabert B, Gierach GL, Wentzensen N, Cronin KA, Sherman ME. Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. J Clin Oncol. 2013;31(17):2146.PubMedPubMedCentral Yang HP, Anderson WF, Rosenberg PS, Trabert B, Gierach GL, Wentzensen N, Cronin KA, Sherman ME. Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. J Clin Oncol. 2013;31(17):2146.PubMedPubMedCentral
33.
go back to reference Pastor-Barriuso R, López-Abente G. Changes in period and cohort effects on haematological cancer mortality in Spain, 1952–2006. BMC Cancer. 2014;14(1):1–12. Pastor-Barriuso R, López-Abente G. Changes in period and cohort effects on haematological cancer mortality in Spain, 1952–2006. BMC Cancer. 2014;14(1):1–12.
34.
go back to reference Luo L. Assessing validity and application scope of the intrinsic estimator approach to the age–period–cohort problem. Demography. 2013;50(6):1945–67.PubMed Luo L. Assessing validity and application scope of the intrinsic estimator approach to the age–period–cohort problem. Demography. 2013;50(6):1945–67.PubMed
35.
go back to reference Rosenberg PS, Check DP, Anderson WF. A web tool for age–period–cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Prev Biomarkers. 2014;23(11):2296–302. Rosenberg PS, Check DP, Anderson WF. A web tool for age–period–cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Prev Biomarkers. 2014;23(11):2296–302.
36.
go back to reference Anderson WF, Rosenberg PS, Menashe I, Mitani A, Pfeiffer RM. Age-related crossover in breast cancer incidence rates between black and white ethnic groups. JNCI J Natl Cancer Inst. 2008;100(24):1804–14.PubMed Anderson WF, Rosenberg PS, Menashe I, Mitani A, Pfeiffer RM. Age-related crossover in breast cancer incidence rates between black and white ethnic groups. JNCI J Natl Cancer Inst. 2008;100(24):1804–14.PubMed
37.
go back to reference Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550.PubMedPubMedCentral Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550.PubMedPubMedCentral
38.
go back to reference Ding Y, Zhou J, Yang J, Laflamme L. Demographic and regional characteristics of road traffic injury deaths in Jiangsu Province, China. J Public Health. 2017;39(3):e79–87. Ding Y, Zhou J, Yang J, Laflamme L. Demographic and regional characteristics of road traffic injury deaths in Jiangsu Province, China. J Public Health. 2017;39(3):e79–87.
39.
go back to reference Vynnycky E, Fine PEM. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect. 1997;119(2):183–201.PubMedPubMedCentral Vynnycky E, Fine PEM. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect. 1997;119(2):183–201.PubMedPubMedCentral
41.
go back to reference Wu P, Cowling BJ, Schooling CM, Wong IO, Johnston JM, Leung CC, Tam C-M, Leung GM. Age–period–cohort analysis of tuberculosis notifications in Hong Kong from 1961 to 2005. Thorax. 2008;63(4):312–6.PubMed Wu P, Cowling BJ, Schooling CM, Wong IO, Johnston JM, Leung CC, Tam C-M, Leung GM. Age–period–cohort analysis of tuberculosis notifications in Hong Kong from 1961 to 2005. Thorax. 2008;63(4):312–6.PubMed
42.
go back to reference Strachan DP, Powell KJ, Thaker A, Millard FJ, Maxwell JD. Vegetarian diet as a risk factor for tuberculosis in immigrant south London Asians. Thorax. 1995;50(2):175–80.PubMedPubMedCentral Strachan DP, Powell KJ, Thaker A, Millard FJ, Maxwell JD. Vegetarian diet as a risk factor for tuberculosis in immigrant south London Asians. Thorax. 1995;50(2):175–80.PubMedPubMedCentral
43.
go back to reference Willis MD, Winston CA, Heilig CM, Cain KP, Walter ND, Mac Kenzie WR. Seasonality of tuberculosis in the United States, 1993–2008. Clin Infect Dis. 2012;54(11):1553–60.PubMed Willis MD, Winston CA, Heilig CM, Cain KP, Walter ND, Mac Kenzie WR. Seasonality of tuberculosis in the United States, 1993–2008. Clin Infect Dis. 2012;54(11):1553–60.PubMed
44.
go back to reference Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, Unwin N. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health. 2007;7(1):1–8. Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, Unwin N. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health. 2007;7(1):1–8.
46.
go back to reference Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis—a systematic review. BMC Public Health. 2008;8(1):1–12. Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis—a systematic review. BMC Public Health. 2008;8(1):1–12.
47.
go back to reference Khatri GR, Frieden TR. Controlling tuberculosis in India. N Engl J Med. 2002;347(18):1420–5.PubMed Khatri GR, Frieden TR. Controlling tuberculosis in India. N Engl J Med. 2002;347(18):1420–5.PubMed
48.
go back to reference Winston CA, Navin TR. Birth cohort effect on latent tuberculosis infection prevalence, United States. BMC Infect Dis. 2010;10(1):1–4. Winston CA, Navin TR. Birth cohort effect on latent tuberculosis infection prevalence, United States. BMC Infect Dis. 2010;10(1):1–4.
49.
go back to reference Padmapriyadarsini C, Shobana M, Lakshmi M, Beena T, Swaminathan S. Undernutrition & tuberculosis in India: situation analysis & the way forward. Indian J Med Res. 2016;144(1):11.PubMedPubMedCentral Padmapriyadarsini C, Shobana M, Lakshmi M, Beena T, Swaminathan S. Undernutrition & tuberculosis in India: situation analysis & the way forward. Indian J Med Res. 2016;144(1):11.PubMedPubMedCentral
50.
go back to reference Marimuthu P. Tuberculosis prevalence and socio-economic differentials in the slums of four metropolitan cities of India. Indian J Tuberc. 2016;63(3):167–70.PubMed Marimuthu P. Tuberculosis prevalence and socio-economic differentials in the slums of four metropolitan cities of India. Indian J Tuberc. 2016;63(3):167–70.PubMed
51.
go back to reference Prasad R, Suryakant RG, Singhal S, Dawar R, Agarwal GG. A case-control study of tobacco smoking and tuberculosis in India. Ann Thorac Med. 2009;4(4):208.PubMedPubMedCentral Prasad R, Suryakant RG, Singhal S, Dawar R, Agarwal GG. A case-control study of tobacco smoking and tuberculosis in India. Ann Thorac Med. 2009;4(4):208.PubMedPubMedCentral
Metadata
Title
Trends in incidence and mortality of tuberculosis in India over past three decades: a joinpoint and age–period–cohort analysis
Authors
Deepak Dhamnetiya
Priyanka Patel
Ravi Prakash Jha
Neha Shri
Mayank Singh
Krittika Bhattacharyya
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01740-y

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine